MedTrace Logo

The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA

NCT04598698 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2024-08-30

No results posted yet for this study

Summary

Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visits for collection of blood and saliva and completion of study questionnaires.

Conditions

  • Endometriosis

Sponsors & Collaborators

  • Dot Laboratories, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2023-05-03
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598698 on ClinicalTrials.gov